Thermo Fisher Scientific Strengthens Portfolio of Endotoxin-Free Plasmid DNA Isolation Kits

Thermo Fisher Scientific Inc. , the world leader in serving science, has expanded its line of endotoxin-free plasmid DNA isolation products with the launch of the PureLink Expi Endotoxin-Free Maxi Plasmid Purification Kit. With a simple and fast protocol for isolation, the kit allows researchers to yield up to 1.5 mg of endotoxin-free, advanced transfection-quality... Read more

The next stage of PCR

Eppendorf’s new Mastercycler® X50 Hamburg, May 2017 Eppendorf’s new Mastercycler® X50 accommodates PCR with outstanding speed and optimization capabilities. With heating rates of 10°C/s average, Eppendorf provides a very fast 96 well cycler compatible with standard format consumables.  PCR optimization reaches a new magnitude with the innovative 2D-Gradient, which allows totally new expectations with regards... Read more

Hitachi High-Technologies Starts Capital and Business Alliance in the Genetic Testing Business

– Contributing to people’s health by promoting the spread of genetic testing equipment in the healthcare field – Tokyo, Japan, May 15, 2017, Hitachi High-Technologies Corporation (TSE: 8036, Hitachi High-Tech) agreed to start a capital and business alliance (hereinafter, “the Alliance”) with Precision System Science Co., Ltd. (PSS) relating to the genetic testing business using... Read more

Roka Bioscience, Inc. Announces Distribution Partnership with FoodChek Systems Inc.

WARREN, N.J., May 8, 2017 /PRNewswire/ — Roka Bioscience, Inc. (“Roka”) (NASDAQ: ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, announced today that it has entered into an 5-year non-exclusive distribution agreement  with FoodChek Systems Inc. to distribute their lines of both proprietary Actero™ ELITE Enrichment Media... Read more

Roche launches AVENIO ctDNA Analysis Kits for Oncology Research

Basel, 08 May 2017 First blood-based distributed oncology tests covering all four mutation classes Three test choices provide accurate insights into different stages and types of cancer Streamlined testing generates results in five days Roche (SIX: RO, ROG; OTCQX:RHHBY) today announced the global commercial launch of the AVENIO circulating tumor DNA (ctDNA) Analysis Kits, a... Read more

Roche launches AVENIO ctDNA Analysis Kits for Oncology Research

Basel, 08 May 2017 Roche launches AVENIO ctDNA Analysis Kits for Oncology Research First blood-based distributed oncology tests covering all four mutation classes Three test choices provide accurate insights into different stages and types of cancer Streamlined testing generates results in five days Roche (SIX: RO, ROG; OTCQX:RHHBY) today announced the global commercial launch of... Read more

VWR Enters into Definitive Agreement with Avantor

Avantor to Acquire VWR for $33.25 per Common Share In An All Cash Transaction Valued At $6.4 Billion Avantor’s Acquisition of VWR Will Create a Vertically Integrated, Global Player in Manufacturing and Supply Chain Solutions for the Life Sciences, Advanced Technologies, and Research Industries Combined Company Will Provide Broad Offerings and Compelling Solutions for Customers... Read more